Description: SanBio Company Limited develops, produces, and sells regenerative cell medicines for central nervous system. It develops SB623, a therapeutic product for various stroke patients. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Home Page: www.sanbio.com
St. Luke Tower
Tokyo,
104-0044
Japan
Phone:
81 3 6264 3481
Officers
| Name | Title |
|---|---|
| Mr. Toru Kawanishi | Co-Founder & Executive Chairman |
| Mr. Keita Mori MBA | Co-Founder, President, Executive Officer, CEO & Representative Director |
| Mr. Yoshihiro Kakutani | Corporate Officer of Management Administration |
| Mr. Naoki Tsukahara | Senior Corporate Officer |
| Dr. Kazumi Sawaguchi Ph.D. | Corporate Officer and Head of Japan Regulatory Affairs & Quality Compliance Japan |
| Mr. Keizo Nakada | Corporate Officer & Head of Production |
| Mr. Shinya Hirata | Corporate Officer & Head of Research and Development |
| Mr. Dai Chida | Senior Scientific Advisor |
Exchange: OTCGREY
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 38.6216 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 29 |